Skip to main content
. 2019 May 29;8(11):e012503. doi: 10.1161/JAHA.119.012503

Figure 1.

Figure 1

ARIC study visits and the number of participants starting antidepressants across each visit by class (SSRI vs non‐SSRI) with arrows width weighted by the number of participants (n=2027). ARIC indicates Atherosclerosis Risk in Communities study; SSRI, selective serotonin reuptake inhibitor.